The BCG vaccine, given to newborns across Singapore and Asia to protect against tuberculosis, is safe for most babies. However, for a tiny group of children born with primary immunodeficiency (PID)—rare genetic conditions that severely weaken the immune system—the vaccine itself can become dangerous, spreading throughout their bodies instead of protecting them.
A new case study published in Frontiers in Pediatrics examined three young children (aged 3 to 9.5 months) with different types of PID who developed disseminated BCG disease after vaccination. Each child had a different genetic condition affecting their immune system, but all faced the same life-threatening infection.
Contezolid offers safer treatment without blood damage
Doctors traditionally treated this complication with linezolid, an antibiotic that works effectively against the infection. But linezolid carries a serious risk: it can damage bone marrow and blood cell production, particularly dangerous for children already struggling with immune problems. The research team instead used contezolid, a newer antibiotic, to treat all three children.
Over a year-long treatment period, all three children improved significantly with no signs of relapse. Importantly, contezolid didn't cause the blood-damaging side effects seen with linezolid. The children experienced no liver damage, kidney problems, or nerve damage either. This matters because it means children won't have to choose between treating a dangerous infection and risking serious damage to their developing bodies.
Singapore's screening programme catches most cases early
Singapore's newborn screening programme is world-class and now catches many cases of primary immunodeficiency through blood tests at birth. If your child is diagnosed with PID, your medical team will carefully consider whether vaccination timing needs adjustment or whether the standard BCG vaccine is safe for your child specifically.
One important note: in these three cases, the children also received stem cell transplants to help restore their immune systems. So the recovery wasn't due to contezolid alone. However, the research shows that contezolid played a crucial role in safely managing the infection while their immune systems were being rebuilt.
What you can do if your child has PID
- If your child is diagnosed with primary immunodeficiency at newborn screening, discuss BCG vaccine timing and safety directly with your child's immunologist before vaccination.
- If your child develops disseminated BCG disease, ask your medical team about contezolid as a treatment option, since it appears safer than older antibiotics for young children.